sulfachlorpyridazine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| anti-infectives, sulfonamides | 2498 | 80-32-0 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine.
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000892 | Anti-Infective Agents, Urinary |
| CHEBI has role | CHEBI:36047 | antibacterial drugs |
| CHEBI has role | CHEBI:50502 | dihydropteroate synthase inhibitors |
| CHEBI has role | CHEBI:88188 | allergenic drug |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Cattle | Diarrhea caused or complicated by Escherichia coli (colibacillosis) | Indication |
| Dog | Infectious tracheobronchitis | Indication |
| Dog | Iinfections caused by Escherichia coli | Indication |
| Dog | Infections caused by gram-positive and gram-negative organisms | Indication |
| Swine | Diarrhea caused or complicated by Escherichia coli (colibacillosis) | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Prinzone Bolus, Pyradan Bolus, Vetisulid Bolus | Boehringer lngelheim Animal Health USA Inc. | 1 |
| Prinzone Injection, Pyradan Injection, Vetisulid Injection | Boehringer lngelheim Animal Health USA Inc. | 1 |
| Vetisulid Tablets | Boehringer lngelheim Animal Health USA Inc. | 1 |
| Vetisulid | Huvepharma EOOD | 1 |
| Vetisulid Oral Suspension | Huvepharma EOOD | 1 |
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 6.14 | acidic |
| pKa2 | 2.48 | Basic |
| pKa3 | 1.93 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D05948 | KEGG_DRUG |
| C0038672 | UMLSCUI |
| CHEBI:59057 | CHEBI |
| CHEMBL1443577 | ChEMBL_ID |
| DB11461 | DRUGBANK_ID |
| D013410 | MESH_DESCRIPTOR_UI |
| 6634 | PUBCHEM_CID |
| 12634 | IUPHAR_LIGAND_ID |
| 910 | INN_ID |
| P78D9P90C0 | UNII |
| 2476008 | RXNORM |
| 002830 | NDDF |
| 8701002 | SNOMEDCT_US |
Pharmaceutical products:
None